| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/14/2000 | CN1256630A Parvitamin A correlation molecule for treating non-insulin dependent diabetes mellitus (NIDDM) |
| 06/13/2000 | US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents |
| 06/13/2000 | US6075059 Comprising water, a local anesthetic agent, and a sugar alcohol |
| 06/13/2000 | US6075032 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| 06/13/2000 | US6075020 Method of regulating immune function |
| 06/13/2000 | US6075008 Method for promoting cell proliferation and growth |
| 06/13/2000 | US6074839 Transforming growth factor αHI |
| 06/13/2000 | US6074657 Administration of an injectable antibiotic in the ear of an animal |
| 06/13/2000 | US6074643 Site-directed chemotherapy of metastases |
| 06/13/2000 | CA2125667C Fluorocarbon aerosol medicaments |
| 06/08/2000 | WO2000033218A1 A global method for mapping property spaces |
| 06/08/2000 | WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 06/08/2000 | WO2000033065A1 In vivo biosensor apparatus and method of use |
| 06/08/2000 | WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics |
| 06/08/2000 | WO2000032805A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 06/08/2000 | WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 06/08/2000 | WO2000032775A1 Pth1r and pth3r receptors |
| 06/08/2000 | WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof |
| 06/08/2000 | WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 06/08/2000 | WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 06/08/2000 | WO2000032766A1 Human vanilloid receptors and their uses |
| 06/08/2000 | WO2000032752A1 Psca: prostate stem cell antigen and uses thereof |
| 06/08/2000 | WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/08/2000 | WO2000032624A2 Uncoupling protein 5 - ucp5 |
| 06/08/2000 | WO2000032267A2 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/08/2000 | WO2000032237A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 06/08/2000 | WO2000032232A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease |
| 06/08/2000 | WO2000032231A1 Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | WO2000032210A1 Pharmaceutical composition containing fish oil, vitamin e and c and acetylsalicyl acid against arteriosclerosis |
| 06/08/2000 | WO2000032198A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion |
| 06/08/2000 | WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 06/08/2000 | WO2000032190A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 06/08/2000 | WO2000032187A1 A new pharmaceutical composition |
| 06/08/2000 | WO2000032186A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 06/08/2000 | WO2000032185A1 Use of effectors of the central cholinergic nervous system |
| 06/08/2000 | WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/08/2000 | WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 06/08/2000 | WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis |
| 06/08/2000 | WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor |
| 06/08/2000 | WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose |
| 06/08/2000 | WO2000016760A3 New use of prostaglandin e2 antagonists |
| 06/08/2000 | WO2000014275A3 Two-colour differential display, used as a method for detecting regulated genes |
| 06/08/2000 | WO2000014200A3 Essential bacterial genes and their use |
| 06/08/2000 | WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 06/08/2000 | WO2000011191A3 Tpl-2/cot kinase and methods of use |
| 06/08/2000 | WO2000010550A3 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 06/08/2000 | WO2000010533A3 Compositions and methods for treating intracellular infections |
| 06/08/2000 | WO2000004137A9 Human aspartic proteases |
| 06/08/2000 | DE19959689A1 Liposome composition for tumor, especially breast cancer, therapy comprises an alkyl phospholipid with antineoplastic activity and one or more antiestrogens |
| 06/08/2000 | DE19958198A1 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs) |
| 06/08/2000 | DE19855426A1 Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen Means for the therapy and prophylaxis of rheumatic arthritic diseases and for the prophylaxis of cardiovascular diseases |
| 06/08/2000 | CA2353795A1 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 06/08/2000 | CA2353602A1 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics |
| 06/08/2000 | CA2353550A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/08/2000 | CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 06/08/2000 | CA2352789A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion |
| 06/08/2000 | CA2352539A1 Recombinant soluble fc receptors |
| 06/08/2000 | CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 06/08/2000 | CA2351731A1 Compositions and methods for regulating bacterial pathogenesis |
| 06/08/2000 | CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 06/08/2000 | CA2350241A1 A global method for mapping property spaces |
| 06/08/2000 | CA2349402A1 A new pharmaceutical composition |
| 06/08/2000 | CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2000 | EP1006194A2 C-erbB-2 external domain: GP75 |
| 06/07/2000 | EP1006184A1 IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof |
| 06/07/2000 | EP1006183A1 Recombinant soluble Fc receptors |
| 06/07/2000 | EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 06/07/2000 | EP1005551A2 Tissue factor pathway inhibitor-3 |
| 06/07/2000 | EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme |
| 06/07/2000 | EP1005545A1 Human extracellular matrix-1 |
| 06/07/2000 | EP1005489A1 Novel polypeptides within the growth factor superfamily |
| 06/07/2000 | EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 06/07/2000 | EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 06/07/2000 | EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 06/07/2000 | EP1005364A1 Method of protecting against chronic infections |
| 06/07/2000 | EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 06/07/2000 | EP1005360A1 Antioxidant protein 2, gene and methods of use therefor |
| 06/07/2000 | EP1005348A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 06/07/2000 | EP1005345A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine |
| 06/07/2000 | EP1005344A1 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid x receptor selective agonists |
| 06/07/2000 | EP1005343A1 Use of csaid?tm compounds as inhibitors of angiogenesis |
| 06/07/2000 | EP1005337A1 Pharmacologic drug combination in vagal-induced asystole |
| 06/07/2000 | EP1005336A1 Improved methods and compositions for treating male erectile dysfunction |
| 06/07/2000 | EP1005333A1 Methods and compositions for preventing and treating chronological aging in human skin |
| 06/07/2000 | EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 06/07/2000 | EP0806965A4 Cd44 expression in smooth muscle cells |
| 06/07/2000 | CN1255864A Combination of ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 06/07/2000 | CN1255859A Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
| 06/07/2000 | CN1255850A Topical compsns. |
| 06/07/2000 | CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound |
| 06/06/2000 | US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections |
| 06/06/2000 | US6071962 Oxa acids and related compounds for treating skin conditions |